Silence Therapeutics plc Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Silence Therapeutics plc (SLN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.12% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-05
- Silence Therapeutics plc effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.12%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | 0.12% 10-K · filed 2026-03-05 |